EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features

Matteo Megna, Mario De Lucia, Lucia Gallo, Wanda Lauro, Vincenzo Picone, Gabriella Fabbrocini, Sonia Sofia Ocampo-Garza

Skin Appendage Disorders · 2023 · 9 (3) · 207-210

DOI: 10.1159/000527985 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Skin Appendage Disorders, online erschienen am 08.12.2022. Verfasst von Matteo Megna und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Psoriatic alopecia is considered a type of hair loss occurring in patients with psoriasis. Adalimumab is a fully humanized recombinant anti-TNF-alpha monoclonal antibody approved for treatment of psoriasis and psoriatic arthritis (PsA), rarely related to the occurrence of dermatological disorders. Case Presentation: We report the case of a 56-year-old female with PsA developing psoriatic alopecia and paradoxical psoriasis induced by adalimumab and successfully treated switching to certolizumab, evaluating response at both thrichoscopy and in vivo reflectance confocal microscopy.

Discussion

Among anti-TNF-α agents, certolizumab is the least involved in the development of paradoxical reactions such as psoriatic alopecia and showed to be an effective and safe alternative therapeutic options to manage psoriasis and PsA minimizing the risk of paradoxical reactions.

Schlagwörter

Stichwörter der Autor:innen

AdalimumabCertolizumab pegolIn vivo reflectance confocal microscopyParadoxical psoriasisPsoriatic alopecia

Autor:innen und Institutionen

  • Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Dermatology Department, University Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico.

Zitieren

APA

Megna, M., De Lucia, M., Gallo, L., Lauro, W., Picone, V., Fabbrocini, G., & Ocampo-Garza, S. S. (2023). Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features. Skin Appendage Disorders, 9(3), 207-210. https://doi.org/10.1159/000527985

Vancouver

Megna M, De Lucia M, Gallo L, Lauro W, Picone V, Fabbrocini G, et al. Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features. Skin Appendage Disorders. 2023;9(3):207-210. doi:10.1159/000527985

BibTeX
@article{Megna2023,
  author = {Megna, Matteo and De Lucia, Mario and Gallo, Lucia and Lauro, Wanda and Picone, Vincenzo and Fabbrocini, Gabriella and Ocampo-Garza, Sonia Sofia},
  title = {Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features},
  journal = {Skin Appendage Disorders},
  year = {2023},
  volume = {9},
  number = {3},
  pages = {207--210},
  doi = {10.1159/000527985}
}
Kostenlos starten →